Latin America Single-Use Bioreactors Market (2026-2031)
The Latin America Single-Use Bioreactors Market was valued at $265.3 Million in 2026 and projected to reach to $415.8 Million by 2031, representing a compound annual growth rate of 9.4%. Latin America's single-use bioreactors market is poised for significant growth as biopharmaceutical companies and CDMOs increasingly recognize the advantages of single-use technology in reducing contamination risks, minimizing capital investment, and accelerating time-to-market.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Latin America Single-Use Bioreactors Market Trends and Insights
- This growth trajectory reflects Latin America's increasing adoption of single-use bioreactor technology across biopharmaceutical manufacturing, contract development and manufacturing organizations (CDMOs), and vaccine production facilities.
- Latin America's market expansion is driven by rising investments in biologics infrastructure, regulatory harmonization efforts, and the region's strategic positioning as a manufacturing hub for the Americas. The 9.4% compound annual growth rate (CAGR) through 2031 underscores Latin America's commitment to modernizing bioprocessing capabilities and reducing capital expenditure through single-use systems.
- Latin America is witnessing increased demand from both multinational biopharmaceutical companies establishing regional operations and local manufacturers scaling production capacity.
- Key drivers include cost efficiency advantages, reduced contamination risk, and faster time-to-market benefits that single-use bioreactors provide to Latin America's growing biotech ecosystem..
Key Market Statistics
- CAGR (2026-2031) 9.4% CAGR
- Market Size, 2026 ~USD 265.3 Million
- Forecast, 2031 ~USD 415.8 Million
- Geography Latin America
Latin America Single-Use Bioreactors Market Overview
Strong Regional Growth Momentum :
Latin America's single-use bioreactors market is expanding at a 9.4% CAGR, driven by increasing biopharmaceutical manufacturing investments and growing demand for flexible, cost-effective production solutions across the region.
Brazil Leads Market Expansion :
Brazil dominates Latin America's market with USD 78.1 million in market size, positioning itself as the regional hub for biopharmaceutical innovation and contract manufacturing services.
CDMO and Vaccine Production Growth :
Contract development and manufacturing organizations (CDMOs) and vaccine production facilities in Latin America are rapidly adopting single-use bioreactor technology to enhance operational efficiency and reduce capital expenditure.
Projected Market Expansion :
The market is forecasted to grow from USD 265.3 million in 2026 to USD 415.8 million by 2031, reflecting sustained investment in biopharmaceutical infrastructure and regional manufacturing capabilities.
Latin America Single-Use Bioreactors Market Dynamics
- The region's expanding vaccine production capacity and growing focus on biosimilar manufacturing are key drivers propelling market expansion. Government initiatives supporting pharmaceutical manufacturing localization, coupled with rising healthcare spending and regulatory improvements, are creating favorable conditions for market penetration.
- Brazil and Mexico are emerging as strategic manufacturing hubs, attracting multinational biopharmaceutical investments and fostering a competitive ecosystem that will sustain the projected 9.4% CAGR through 2031..
Market Ecosystem
SINGLE-USE BIOREACTORS MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES
| COMPANY | USE CASE DESCRIPTION | BENEFITS |
|---|---|---|
 |
Deployed six 4,000 L ABEC CSR single-use bioreactors at its Pune facility to support large-scale manufacturing of Novavax’s NVX-CoV2373 vaccine. | Established 24,000 L of single-use production capacity | The 4,000 L systems doubled productivity per unit of floor space, supported accelerated facility startup, and reduced manufacturing cost per dose. |
 |
Implemented Cytiva Xcellerex Disposable Reactors (XDR) for mAb and bispecific antibody production. | Demonstrated that XDR bioreactors can be used effectively for antibody production | The system met all benchmarks for viable cell density, viability, integral viable cell count (IVC), and titer | The real-time CO2 monitoring proved effective, allowing maintenance of optimal culture conditions. |
 |
Implemented Sartorius Ambr and BIOSTAT STR platforms, ranging from process-development systems to 500 L and 2,000 L single-use bioreactors, at its San Diego biologics facility. | Enabled consistent scale-up from development to GMP production, improved process-data continuity, and supported seamless technology transfer for Phase I through commercial biologics manufacturing. |
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
Related Ecosystem
Biotechnology
- Reagents
- Polymerase Chain Reaction (PCR)
- Stem Cells
- Assay Kits
- Flow Cytometers
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Danaher Corporation
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
Key Takeaways
- Latin America's single-use bioreactors market will grow from USD 265.3 million (2026) to USD 415.8 million (2031) at a 9.4% CAGR.
- Latin America is emerging as a preferred manufacturing destination for biopharmaceutical companies seeking cost-effective bioprocessing solutions.
- Single-use bioreactor adoption in Latin America is accelerating due to reduced capital requirements and operational flexibility.
- Latin America's regulatory environment and CDMO expansion are key catalysts driving market penetration through 2031.
Single-Use Bioreactors Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2026 |
| Fastest Growing Segment | CELL & GENE THERAPY (Molecule Type) |
| Forecast Period | 2026-2031 |
| Growth Rate | CAGR of 12% from 2026 to 2031 |
| Largest Segment | BIOPRODUCTION (Application) |
| Market Size Base Year (Billions) | ~USD 5.44 (2026) |
| Revenue Forecast (Billions) | ~USD 9.58 (2031) |
| Segments Covered | Product, Scale Range, Type, Molecule Type, Cell Type, Application, Process Mode, End User |
Latin America Single-Use Bioreactors Market Report Segmentation
8 segment dimensions are covered across the global market.
By Product
- Other Products
- Single-Use Assemblies
- Single-Use Bags
- Single-Use Bioreactor Systems
By Scale Range
- 101-500 L Bioreactors
- 11-100 L Bioreactors
- 501-1,500 L Bioreactors
- >1,500 L Bioreactors
- <=10 L Bioreactors
By Type
- 101-500 L Bioreactors
- 11-100 L Bioreactors
- 2D Single-Use Bags
- 3D Single-Use Bags
- 501-1,500 L Bioreactors
- >1,500 L Bioreactors
- Bubble-Column Single-Use Bioreactors
- Fixed-Bed Single-Use Bioreactors
- Other Single-Use Bioreactors
- Stirred-Tank Single-Use Bioreactors
- Wave-Induced Single-Use Bioreactors
- <=10 L Bioreactors
By Molecule Type
- Cell & Gene Therapy
- Monoclonal Antibodies
- Therapeutic Proteins & Peptides
- Vaccines
By Cell Type
- Bacterial Cells
- Mammalian Cells
- Other Cells
- Yeast Cells
By Application
- Bioproduction
- Process Development
- Research & Development
By Process Mode
- Batch Process Mode
- Feb-Batch Process Mode
- Fed-Batch Process Mode
- Perfusion/Continuous Process Mode
By End User
- Academic & Research Institutes
- Cros & Cmos
- Pharmaceutical & Biotechnology Companies
Target Audience
- Biopharmaceutical Manufacturers : Latin American and multinational biopharmaceutical companies require market intelligence to evaluate single-use bioreactor investments, assess regional manufacturing competitiveness, and plan capacity expansion strategies.
- Contract Development & Manufacturing Organizations (CDMOs) : CDMOs operating in Latin America need detailed market data to benchmark service offerings, identify growth opportunities in vaccine and biosimilar production, and optimize technology investments.
- Equipment & Technology Suppliers : Single-use bioreactor manufacturers and bioprocess equipment vendors require regional market insights to develop go-to-market strategies, identify key accounts, and forecast demand across Latin American markets.
- Private Equity & Investment Firms : Investors evaluating biopharmaceutical and biotech opportunities in Latin America need comprehensive market analysis to assess growth potential, identify acquisition targets, and evaluate portfolio company performance.
- Healthcare & Regulatory Consultants : Consultants advising pharmaceutical companies on Latin American expansion require market data to support feasibility studies, regulatory strategy development, and manufacturing site selection recommendations.
Countries within Latin America - compare and drill down
| Country | 2025 size (native) |
|---|---|
| Brazil | USD 78.1 Million |
| Mexico | USD 40.6 Million |
| Rest Of Latin America | USD 65.3 Million |
Country market size visualization
Reasons to Buy this Report
- Regional Market Sizing & Forecasts : Obtain precise market valuations for Latin America (USD 265.3M in 2026, USD 415.8M in 2031) with country-level breakdowns for Brazil and Mexico to support strategic planning and investment decisions.
- Competitive Landscape Analysis : Understand key players, market share distribution, and competitive strategies specific to Latin America's biopharmaceutical manufacturing sector to identify partnership and expansion opportunities.
- Growth Driver Identification : Gain insights into region-specific growth catalysts including CDMO expansion, vaccine production scaling, biosimilar manufacturing, and government regulatory support driving the 9.4% CAGR.
- Investment & Expansion Strategy : Leverage detailed market intelligence to prioritize market entry, facility location decisions, and capital allocation across Latin America's most promising biopharmaceutical hubs.
- Technology Adoption Trends : Analyze single-use bioreactor adoption patterns, technology preferences, and implementation challenges specific to Latin American manufacturers to optimize product positioning and sales strategies.
Frequently asked questions
What is the current market size of single-use bioreactors in Latin America?
Latin America's single-use bioreactors market was valued at USD 265.3 million in 2026 and is expected to grow to USD 415.8 million by 2031.
What is the projected growth rate for single-use bioreactors in Latin America?
Latin America's single-use bioreactors market is projected to grow at a compound annual growth rate (CAGR) of 9.4% from 2026 to 2031.
Which sectors are driving single-use bioreactor demand in Latin America?
Latin America's demand is primarily driven by biopharmaceutical manufacturing, contract development and manufacturing organizations (CDMOs), vaccine production, and emerging biotech companies seeking cost-efficient production solutions.
Why are single-use bioreactors gaining adoption in Latin America?
Latin America is adopting single-use bioreactors due to lower capital expenditure, reduced contamination risk, faster time-to-market, operational flexibility, and the region's positioning as a manufacturing hub for the Americas.
What factors are expected to support market growth in Latin America through 2031?
Latin America's market growth is supported by increased biopharmaceutical investments, regulatory harmonization, CDMO expansion, multinational company operations, and rising demand for biologics manufacturing capacity.
RESEARCH METHODOLOGY
This research study relied extensively on secondary sources, directories, and databases to identify and collect valuable information for the analysis of the global single-use bioreactors market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives at major market players, and industry consultants, to gather and validate critical qualitative and quantitative information and assess the market's growth prospects. The global market size estimated through secondary research was then triangulated with primary research inputs to arrive at the final market size.
Secondary Research
Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the single-use bioreactors market. The secondary sources used for this study include National Institutes of Health (NIH), National Institute for Bioprocessing Research and Training (NIBRT), Society for Biological Engineering (SBE), Bio-Process Systems Alliance (BPSA), Biotechnology Innovation Organization (BIO), BioProcess International, BioPharm International, BioPlan Associates, Organisation for Economic Co-operation and Development (OECD) R&D Expenditure, National Center for Biotechnology Information (NCBI), World Health Organization (WHO), Food and Drug Administration (FDA); corporate filings such as annual reports, SEC filings, investor presentations, and financial statements; press releases; and trade, business, and professional associations, among others. These sources were also used to obtain key information on major players, market classification and segmentation aligned with industry trends, regional/country-level markets, market developments, and technology perspectives.
Primary Research
In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among others, to obtain and verify critical qualitative and quantitative information and to assess the market's future prospects. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the single-use bioreactors market. These methods were also used extensively to estimate the size of various market subsegments. The research methodology used to estimate the market size includes the following:
Data Triangulation
After arriving at the market size from the market size estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and obtain precise statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed where applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
Single-use bioreactors (SUBs) or disposable bioreactors consist of a disposable bag instead of a typical stainless steel or glass culture vessel. SUBs are based on single-use technology, which uses disposable components to manufacture biopharmaceutical products. The key benefits of single-use bioreactors include reduced risk of cross-contamination, lower capital and operational costs, faster turnaround times, and greater manufacturing flexibility. These advantages make single-use systems particularly attractive for producing biologics, vaccines, and personalized medicines, where flexibility, speed, and sterility are paramount.
The report presents the market size for single-use bioreactor systems, single-use bags, single-use assemblies, and other products that can be incorporated with single-use bioreactors.
Key Stakeholders
- Manufacturers of single-use bioreactors and associated products
- Distributors of single-use bioreactors and related products
- Pharmaceutical and biotechnology companies
- Contract manufacturing companies (CMOs)
- Contract research organizations (CROs)
- Academic and research institutes
- Life sciences companies
- Market research and consulting firms
- Venture capitalists and investors
- Government organizations
- Medical institutes and universities
- Private research firms
Report Objectives
- To define, describe, and forecast the global single-use bioreactors market based on product, type, cell type, process mode, molecule type, application, end user, and region
- To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, opportunities, and challenges)
- To strategically analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the overall single-use bioreactors market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to six main regions, namely, North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa
- To strategically profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
- To track and analyze competitive developments such as acquisitions, product launches, expansions, and R&D activities in the single-use bioreactors market
- To analyze and provide funding & investment activities, brand/product comparative analysis, and vendor valuation & financial metrics of the single-use bioreactors market
Available customizations:
Based on the given market data, MarketsandMarkets offers customization to meet the company’s specific needs. The following customization options are available for this report:
Portfolio Assessment- Product Matrix, which gives a detailed comparison of the product portfolios of the top four companies.
Company Information
- Detailed analysis and profiling of additional market players (up to five).
Geographical Analysis
- A further breakdown of the Rest of Europe single-use bioreactors market, by country
- A further breakdown of the Rest of Asia Pacific single-use bioreactors market, by country
- A further breakdown of the Rest of Latin America single-use bioreactors market, by country
Get the Full Single-Use Bioreactors Market Report
Full forecast, segment splits, and company analysis for all Single-Use Bioreactors Market.
- Canada Single-Use Bioreactors Market
- US Single-Use Bioreactors Market
- Germany Single-Use Bioreactors Market
- UK Single-Use Bioreactors Market
- France Single-Use Bioreactors Market
- Italy Single-Use Bioreactors Market
- Spain Single-Use Bioreactors Market
- China Single-Use Bioreactors Market
- South Korea Single-Use Bioreactors Market
- Japan Single-Use Bioreactors Market
- India Single-Use Bioreactors Market
- Australia Single-Use Bioreactors Market
- Brazil Single-Use Bioreactors Market
- Mexico Single-Use Bioreactors Market
- Rest Of Europe Single-Use Bioreactors Market
- Rest Of Asia Pacific Single-Use Bioreactors Market
- Rest Of Latin America Single-Use Bioreactors Market
- Rest Of GCC Countries Single-Use Bioreactors Market
- Saudi Arabia (Ksa) Single-Use Bioreactors Market
- United Arab Emirates (UAE) Single-Use Bioreactors Market
- GCC Countries Single-Use Bioreactors Market
- Rest Of Middle East Single-Use Bioreactors Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
